| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
Delray Beach, Florida, November 10, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2026. |
| 28 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
(a) Purpose. The PetMed Express, Inc. 2024 Inducement Incentive Plan (as amended and restated, the “Plan”) has two complementary purposes: (i) to attract and retain outstanding individuals to serve as employees and (ii) to increase stock... |
| 21 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution |
| 17 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
THIS EXECUTIVE EMPLOYMENT AGREEMENT (hereinafter “Agreement”) is made and entered into effective as of August 28, 2026, by and between PETMED EXPRESS, INC., a Florida corporation (“Company”), and JEFFREY ALLEN WILLARD, an individual (her... |
| 13 Aug 2026 |
8-K: Results of Operations and Financial Condition
Delray Beach, Florida, August 13, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2026. |
| 12 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
1 4917-9263-2247.3 PETMED EXPRESS, INC. 2024 OMNIBUS INCENTIVE PLAN (As amended on August 11, 2026) 1. Purpose; Effective Date and Amendment; Effect on Prior Plans. Purpose. The PetMed Express, Inc. 2024 Omnibus Incentive Plan (the “Plan... |
| 23 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
#1018487v11 Addendum of Additional Terms This Addendum of Additional Terms (“Addendum”) is attached to the Commercial Contract dated as of July ____, 2026 (the “Commercial Contract”) and alters certain provisions of such Commercial Contr... |
| 26 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On June 23, 2026, Leah A. Solivan, a member of the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”), informed the Company of her decision not to stand for reelection at the Company’s 2026 annual meeting of stockho... |
| 02 Jun 2026 |
8-K: Results of Operations and Financial Condition
Delray Beach, Florida, June 2, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2026. |
| 21 May 2026 |
8-K: Shareholder Director Nominations
The board of directors (the “Board”) of PetMed Express, Inc. (the “Company”) has determined that the Company’s 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”) will be held virtually on August 11, 2026. More detailed infor... |
| 23 Jan 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On January 21, 2026, the Company held its Annual Meeting of Shareholders (“Annual Meeting”). The proposals presented at the Annual Meeting are described in more detail in the Company’s Proxy Statement. As of December 5, 2025, the record ... |
| 09 Dec 2025 |
8-K: Changes in Registrant's Certifying Accountant
We have read PetMed Express, Inc.’s statements included under Item 4.01(a) of its Form 8-K filed on December 9, 2025 and we agree with such statements concerning our firm. |
| 26 Nov 2025 |
8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +2 more
This Change of Control and General Severance Agreement (this “Agreement”), dated November 26, 2025 (the “Effective Date”), is entered into by and between PetMed Express, Inc., a Florida corporation (the “Company”), and Douglas Krulik (th... |
| 13 Nov 2025 |
8-K: Results of Operations and Financial Condition; Notice of Delisting or Failure to Satisfy a Listing Rule
PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq |
| 21 Oct 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
THIS INTERIM EXECUTIVE EMPLOYMENT AGREEMENT (hereinafter “Agreement”) is made and entered into effective as of October 20, 2025, by and between PETMED EXPRESS, INC., a Florida corporation (“Company”), and LESLIE C. G. CAMPBELL, an indivi... |
| 14 Oct 2025 |
8-K: Results of Operations and Financial Condition
Delray Beach, Florida, October 14, 2025, PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the... |
| 07 Oct 2025 |
8-K: Material Impairments; Non-Reliance on Previously Issued Financial Statements +1 more
On October 1, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of PetMed Express, Inc. (the “Company”), upon the recommendation of the Company’s management, concluded that a $1.2 million non-cash impairment of ... |
| 12 Sep 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 8, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved an initial annual base salary of $550,000 for Leslie C.G. Campbell, who began serving as the Company’s Interim Chief Executive Of... |
| 25 Aug 2025 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
On August 20, 2025, PetMed Express, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for ... |
| 12 Aug 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more
THIS SEPARATION AGREEMENT (this “Agreement”) is dated as of August 11, 2025 (the “Effective Date”), by and between Sandra Campos, an individual (“Executive”), and PETMED EXPRESS, INC., a Florida corporation whose principal place of busin... |
Loading...